Search research articles
Contact Us
Filters
Showing results (81-90 of 83) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 83 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1996
Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer
S Welt, A M Scott, C R Divgi, et al.
Cancer Chemotherapy and Pharmacology
|
January 27, 2000
The influence of recombinant human insulin-like growth factor-I (rhIGF-I) on cell growth and cytotoxicity of drugs in childhood rhabdomyosarcoma cell lines and xenograft models
C E Gidding, G S Germain, M B Dilling, et al.
Cancer Research
|
October 20, 2004
Gefitinib enhances the antitumor activity and oral bioavailability of irinotecan in mice
Clinton F Stewart, Markos Leggas, John D Schuetz, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 83) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 83 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1996
Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer
S Welt, A M Scott, C R Divgi, et al.
Cancer Chemotherapy and Pharmacology
|
January 27, 2000
The influence of recombinant human insulin-like growth factor-I (rhIGF-I) on cell growth and cytotoxicity of drugs in childhood rhabdomyosarcoma cell lines and xenograft models
C E Gidding, G S Germain, M B Dilling, et al.
Cancer Research
|
October 20, 2004
Gefitinib enhances the antitumor activity and oral bioavailability of irinotecan in mice
Clinton F Stewart, Markos Leggas, John D Schuetz, et al.
Page
of 9